Patents Assigned to Antiva Biosciences, Inc.
  • COMPOSITIONS AND DOSAGE FORMS FOR TREATMENT OF HPV INFECTION AND HPV-INDUCED NEOPLASIA
    Publication number: 20240150381
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 9, 2024
    Applicant: Antiva Biosciences, Inc.
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • TREATMENT OF HPV-INDUCED NEOPLASIA
    Publication number: 20240139221
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 2, 2024
    Applicant: Antiva Biosciences, Inc
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li
  • TREATMENT OF HPV INFECTION
    Publication number: 20240139220
    Abstract: A pharmaceutically acceptable salt of an acyclic nucleotide phosphoramidate to treat HPV and related conditions including neoplasia, as well as pharmaceutical compositions, morphic forms and dosage forms thereof.
    Type: Application
    Filed: October 31, 2023
    Publication date: May 2, 2024
    Applicant: Antiva Biosciences, Inc.
    Inventors: Barry Aldous, Ramakrishna Gadiraju, Sarah Walter, Oranee Daniels, Gail Maderis, Ankush Argade, Ravichandran Mahalingam, Zhengle Zhao, Zhaoyang Qin, Siyi Jiang, Runyan Li